Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many people with blood cancer have had (a) CAR-T cell therapy and (b) a stem cell transplant in each of the last six months for which data is available.

The table shows the number of patients who have been infused with manufactured chimeric antigen receptor T (CAR T) cells. NHS England/Improvement report that the number of patients who have undergone apheresis (separating a particular blood constituent but returning the remainder to circulation) with an intention to treat will be significantly higher.